Gheorghe Doros, PhD
Professor
Boston University School of Public Health
Biostatistics

PhD, Yale University
MA, Yale University
MS, University of Bucharest
BS, University of Bucharest



Gheorghe Doros is Professor of Biostatistics and director of the Biostatistics Consulting Group. He received his PhD in Statistics from Yale University and joined BUSPH’s Department of Biostatistics in 2006 after spending two years at Eli Lilly, as a member of that company's Drug Discovery and Toxicology department. Dr. Doros’s research on methodological approaches and strategies has been concentrated in the area of clinical trials, more specifically on Bayesian approaches to clinical trials and the area of placebo response in clinical trials. The outcome of his work has been a corner stone in developing a host of collaborations with outstanding faculty, clinicians, and researchers at the Boston University Medical Campus and at other institutions. These productive collaborations have resulted in several federally funded grants. Dr. Doros authored and co-authored many peer-reviewed publications of original and innovative research which has had a major impact on the field. On the majority of publications, Dr. Doros is the lead statistician author. He demonstrated continuing record of multidisciplinary research that has had a major impact on the rapidly changing field. His publications on clinical trials; most proposing the design, analysis and new methodologies or of significant contributions to this field.

Dr. Doros is a very active and effective teacher and mentor in the department of Biostatistics. His teaching philosophy is to pursue an active approach to learning and to engage students to think critically. He taught core and elective courses for Master and PhD-level courses. The excellent course evaluations he received attests to his ability in engaging students in active learning. Dr. Doros has been awarded the excellence in teaching three times in three years.

On a national level, Dr. Doros has served as an Associate Editor for the BioMed Central’s journal Trials and as a reviewer for a number of academic journals. He served as a member of the merit review subcommittee for Epidemiology of the Department of Veteran Affairs and a member NHLBI-Ancillary Studies in Clinical Trials between 2012 and 2014. He has served as a statistical expert on a number of Independent Data Monitoring Committee(IDMC) for clinical trials and clinical programs. He served or seves as a senior consultant on multicenter trials and/or programs for the following organizations Pfizer, Takeda, Avanir, Sarepta and Children's Hospital.

Member
Boston University
BU-BMC Cancer Center




Screening for AL Amyloidosis in Smoldering Multiple Myeloma
03/01/2024 - 02/29/2028 (Subcontract PI)
Tufts Medical Center, Inc. NIH NCI
5R01CA279808-02

Salary Support for Gheorghe Doros, PhD
09/01/2025 - 08/31/2026 (PI)
Baim Institute for Clinical Research


General support for clinical studies at Baim Institute
09/01/2025 - 08/31/2026 (PI)
Baim Institute for Clinical Research


Biostatisics VA Support - Doros Group
08/26/2021 - 08/25/2026 (PI)
Department of Veterans Administration


General support for clinical studies at Baim Institute 24'-25'
09/01/2024 - 08/31/2025 (PI)
Baim Institute for Clinical Research


General support for clinical studies at Baim Institute
09/01/2024 - 08/31/2025 (PI)
Baim Institute for Clinical Research


Mechanistic underpinnings of increased adipose tissue in HFpEF
07/01/2019 - 06/30/2025 (Key Person)
PI: Flora Sam, MD
NIH/National Heart, Lung, and Blood Institute
5R01HL145985-04

BAIM Institute Student Suppport - Doros Group - for Luke Zheng
09/01/2023 - 09/01/2024 (PI)
Baim Institute for Clinical Research


General support for clinical studies at Baim Institute
09/01/2023 - 08/31/2024 (PI)
Baim Institute for Clinical Research


BAIM Institute Student Suppport - Doros Group - for Daniel Kojis
09/01/2023 - 08/31/2024 (PI)
Baim Institute for Clinical Research


Showing 10 of 23 results. Show All Results


Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Website       Copy PMIDs To Clipboard

  1. Avila Rodriguez AM, Hu X, Varga C, Comenzo R, Sarosiek S, Sloan JM, Sanchorawala V, Doros G, Quillen K. Comparable peri-transplant mortality and incidence of febrile neutropenia after high-dose melphalan and autologous stem cell transplantation in patients with plasma cell dyscrasias treated as outpatient versus inpatient. Br J Haematol. 2025 Oct; 207(4):1679-1683.View Related Profiles. PMID: 40898649; DOI: 10.1111/bjh.70104;
     
  2. Alameddine D, Hamouda M, Doros G, Conte MS, Rosenfield K, Strong MB, Menard MT, Farber A, Hamdan A, Malas M, Ochoa Chaar CI. Insulin therapy and outcomes of revascularization procedures for chronic-limb threatening ischemia in the BEST-CLI trial. J Vasc Surg. 2025 Aug 29.View Related Profiles. PMID: 40886741; DOI: 10.1016/j.jvs.2025.08.033;
     
  3. Jones DW, Farber A, Armstrong DG, Azene E, Duncan A, Todoran TM, Doros G, Strong MB, Rosenfield K, Conte MS, Menard MT. Characteristics of multidisciplinary limb preservation teams and their impact on outcomes in the BEST-CLI trial. J Vasc Surg. 2025 Aug 28.View Related Profiles. PMID: 40885461; PMCID: PMC12416768; DOI: 10.1016/j.jvs.2025.08.028;
     
  4. Beckman JA, Drooz AT, Farber A, Hamdan A, Huber T, Hussein M, Jaff MR, Kashyap VS, McGinigle KL, Menard MT, Rosenfield K, Semel ME, Strong MB, Doros G, Creager MA. The Impact of Coronary Artery Disease in Patients With Peripheral Artery Disease Undergoing Lower-Extremity Revascularization for Chronic Limb-Threatening Ischemia. Circulation. 2025 Aug 05; 152(5):346-348.View Related Profiles. PMID: 40758772; PMCID: PMC12327766; DOI: 10.1161/CIRCULATIONAHA.124.072241;
     
  5. Vemulapalli S, Doros G, Weissler EH, Jones WS, Li S, Obrien SM, Beckman JA, Hamburg NM, Jaff MR, Strong MB, Rosenfield K, Menard MT, Farber A, Patel MR. Prediction of 1-Year Major Adverse Cardiovascular Events in Chronic Limb Threatening Ischemia. JACC Adv. 2025 Aug; 4(8):101959.View Related Profiles. PMID: 40695135; PMCID: PMC12296431; DOI: 10.1016/j.jacadv.2025.101959;
     
  6. Siracuse JJ, Kaufman JA, Farber A, Menard MT, Rosenfield K, Conte MS, Schanzer A, Powell RJ, Venermo M, Doros G, Faries P, Strong MB, Dake MD. Antiproliferative endovascular drug technology is associated with fewer major reinterventions after femoropopliteal interventions for chronic limb-threatening ischemia. J Vasc Surg. 2025 Oct; 82(4):1375-1382.View Related Profiles. PMID: 40464723
     
  7. Steflea R, Stroescu RF, Gafencu M, Chisavu F, Stoicescu ER, Doros G. ENDOCRINE AND GROWTH ABNORMALITIES IN CHILDREN WITH KIDNEY FAILURE ON MAINTENANCE HEMODIALYSIS - EXPERIENCE OF A SINGLE CENTER FROM WESTERN ROMANIA. Acta Endocrinol (Buchar). 2024; 20(3):393-400. PMID: 40530097; PMCID: PMC12169833; DOI: 10.4183/aeb.2024.393;
     
  8. Kashyap VS, Beckman JA, Doros G, Menard MT, Rosenfield K, Creager MA, Tuttle KR, McGinigle KL, Huber T, Kinlay S, Drooz AT, Strong MB, Weinberg I, Farber A, Jaff MR. Optimal Medical Therapy Is Associated With Improved Limb Outcomes in PAD Patients: A BEST-CLI Substudy. J Am Coll Cardiol. 2025 Apr 22; 85(15):1568-1572.View Related Profiles. PMID: 40240095
     
  9. Farber A, Menard MT, Conte MS, Rosenfield K, Hicks CW, Doros G, Strong MB, Houlind K, Kolh P, Siracuse JJ. Editor's Choice - Bypass After Failed Endovascular Intervention Is Associated with an Increased Risk of Above Ankle Amputation Among Patients with Chronic Limb Threatening Ischaemia in a Randomised Trial Population. Eur J Vasc Endovasc Surg. 2025 Jul; 70(1):107-113.View Related Profiles. PMID: 40188865
     
  10. Shah KB, Aridi H, Dake MD, Doros G, Farber A, Menard MT, Motaganahalli R, Ochoa Chaar C, Rosenfield K, Scali ST, Shah SK, Strong MB, Upchurch GR, Robinson WP. Age-Related Outcomes After Revascularization for Chronic Limb-Threatening Ischemia: An Analysis of BEST-CLI. Circ Cardiovasc Interv. 2025 Jun; 18(6):e014833.View Related Profiles. PMID: 40177778; PMCID: PMC12173781; DOI: 10.1161/CIRCINTERVENTIONS.124.014833;
     
Showing 10 of 373 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 373 publications over 23 distinct years, with a maximum of 41 publications in 2014

YearPublications
20031
20041
20051
20063
20077
20084
200914
201014
201115
20129
201321
201441
201539
201628
201739
201836
201923
202011
202114
202214
20239
202413
202516


For COVID-19 Patients, Could Breathing Easier Be as Simple as Flipping Over?

Mirage News 4/18/2020

Medtronic data show no paclitaxel-mortality link amid FDA warnings

MedTech Dive 1/23/2019

Patient-level survival analysis demonstrates no link between paclitaxel dose and mortality in patients treated with IN.PACT Admiral DCB

Vascular News 1/22/2019

Medical Campus Sees Eight New Full Professorships

BU Today 3/8/2018

2008-2010 Boston University School of Public Health: Excellence in Teaching Award
Contact for Mentoring:

801 Massachusetts Ave Crosstown Center
Boston MA 02118
Google Map

617.638.5871
Download vCard

Doros's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
See all (835) concept(s)
_
Media Mentions
_
Co-Authors
See all (96) people
_
Similar People
See all (60) people
_
Same Department
Search Department